Smith Miller and Patch, Inc. et al.; Withdrawal of Approval of 14 New Drug Applications

الملخص

The Food and Drug Administration (FDA) is withdrawing approval of 14 new drug applications (NDAs) from multiple holders of these applications. The basis for the withdrawals is that the holders of the applications have repeatedly failed to file required annual reports for the applications.